While the biopharma industry’s response to COVID-19 – creating and launching multiple breakthrough innovations in record time – has generated enormous confidence and respect for biopharma, it has also reinvigorated the drug pricing debate. Now, more than ever, it’s essential for companies to have a strategic and robust approach to pricing.

In this virtual Forum, Laurie Halloran (President & CEO of Halloran Consulting Group), Laura Randa (Chief Executive Officer, Randa BioPharma Solutions), Jennifer Petrillo Billet (Director, Sage Therapeutics) and Alex Santini (Senior Vice President of Market Access, Nektar Therapeutics)  will share their guidance and expertise on developing and implementing drug pricing, value, and access strategies. Topics will include: 

• The importance of planning, with a focus on late-stage clinical trials
• Best practices for working with payors
• Market access and reimbursement – at home and abroad

Webinar link will be emailed to participants the day before - you can also access it from the "Live Stream" tab below. This event is for members-only.

NOTE: MassBio makes every effort to accommodate our entire community at each of our events. Please let us know at least 3 days in advance of the event if you require special accommodations, such as captioning.